Operator

Good afternoon, ladies and gentlemen. Welcome to the Glass House Brands First Quarter 2026 Earnings Call.

Matters discussed today during today's conference call may constitute forward-looking statements that are subject to the risks and uncertainties related to the Glass House Brands' future financial or business performance. Actual results could differ materially from those anticipated in those forward-looking statements. The risk factors that may affect the results are detailed in the Glass House Brands' periodic filings and registration statements. These documents may be accessed via the SEDAR or SEDAR+ database.

I'd also like to remind everyone that this call is being recorded today, Wednesday, May 13, 2026.

On today's call we have Kyle Kazan, Co-Founder and Chairman; and the Chief Executive Officer of Glass House Brands and the Chief Financial Officer, Mark Vendetti. Following prepared remarks, management will open up the call to the analyst questions. Also joining for the questions is Graham Farrar, Co-Founder and President.

And with that, I'll turn the call over to Kyle Kazan.

Kyle Kazan
Co-founder, Chairman & CEO

Good afternoon. Thank you, operator, and to all of you for joining today's call. For greater detail on results, please refer to our first quarter 2026 earnings press release and financial filings.

Before I get into our first quarter results, I want to acknowledge the landmark event within our industry, the rescheduling of medical cannabis to Schedule III. This represents the most important drug reform in my lifetime and